Vertex Pharmaceuticals Inc
BMV:VRTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
BMV:VRTX
|
US |
|
C
|
CSL Ltd
XMUN:CSJ
|
AU |
|
T
|
TotalEnergies SE
XMUN:TOTB
|
FR |
|
K
|
Keurig Dr Pepper Inc
XMUN:DP5
|
US |
|
JPMorgan Chase & Co
F:CMC
|
US |
|
Vita Coco Company Inc
NASDAQ:COCO
|
US |
|
W
|
Wolters Kluwer NV
XMUN:WOSB
|
NL |
|
D
|
Deutsche Wohnen SE
XMUN:DWNI
|
DE |
|
Ozon Holdings PLC
MOEX:OZON
|
CY |
|
B
|
Boeing Co
XMUN:BCO
|
US |
|
A
|
Applied Materials Inc
DUS:AP2
|
US |
|
Naspers Ltd
F:NNW
|
ZA |
|
W
|
Wells Fargo & Co
DUS:NWT
|
US |
|
E
|
EOG Resources Inc
XMUN:EO5
|
US |
Wall St Price Targets
VRTX Price Targets Summary
Vertex Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for VRTX is 9 841.89 MXN with a low forecast of 5 872.28 MXN and a high forecast of 11 858.2 MXN.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VRTX's stock price target?
Price Target
9 841.89
MXN
According to Wall Street analysts, the average 1-year price target for VRTX is 9 841.89 MXN with a low forecast of 5 872.28 MXN and a high forecast of 11 858.2 MXN.
What is the Revenue forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 10%.
What is the Operating Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
15%
Over the last 14 years, the compound annual growth rate for Operating Income has been 24%. The projected CAGR for the next 8 years is 15%.
What is the Net Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
15%
Over the last 14 years, the compound annual growth rate for Net Income has been 42%. The projected CAGR for the next 8 years is 15%.
